Prot# GZ/SAR402671 - ACT1482: Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GZ/SAR402671 in Patients with Early-Stage Parkinson’s Disease Carrying a GBA Mutation o

Project: Research project

Project Details

StatusActive
Effective start/end date2/13/172/13/23

Funding

  • Sanofi US Services Inc. (GZ/SAR402671 - ACT1482)